Literature DB >> 1337394

Long-term clinical observations on feline immunodeficiency virus infected asymptomatic carriers.

T Ishida1, A Taniguchi, S Matsumura, T Washizu, I Tomoda.   

Abstract

Eleven feline immunodeficiency virus (FIV) infected asymptomatic carrier (AC) cats were observed for 2 years for development of acquired immunodeficiency syndrome (AIDS). Four of the 11 (36.4%) showed progression of the clinical stage. Persistent generalized lymphadenopathy was noted in three cats as the first sign of illness after the AC phase, while the other showed lymphadenopathy with signs of AIDS-related complex. In all four cats the AIDS-related complex stage lasted for 10 months or longer, and two showed progression of the disease into AIDS. The two cats showing AIDS illnesses died within approximately 1 year after they had developed persistent generalized lymphadenopathy. Pathology confirmed the diagnosis of AIDS characterized by the presence of depletion lesions in the lymphoid organs, and of severe infections of an opportunistic nature. The overall mortality of FIV infected AC cats during a 2 year period was two out of 11 (18.2%). These cats showed decreased concanavalin A mitogen response of peripheral blood mononuclear cells as the disease progressed.

Entities:  

Mesh:

Year:  1992        PMID: 1337394     DOI: 10.1016/0165-2427(92)90117-9

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  9 in total

1.  Parameters of disease progression in long-term experimental feline retrovirus (feline immunodeficiency virus and feline leukemia virus) infections: hematology, clinical chemistry, and lymphocyte subsets.

Authors:  R Hofmann-Lehmann; E Holznagel; P Ossent; H Lutz
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

Review 2.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

Review 3.  HIV-1 and drug abuse comorbidity: Lessons learned from the animal models of NeuroHIV.

Authors:  Susmita Sil; Annadurai Thangaraj; Ernest T Chivero; Fang Niu; Muthukumar Kannan; Ke Liao; Peter S Silverstein; Palsamy Periyasamy; Shilpa Buch
Journal:  Neurosci Lett       Date:  2021-03-29       Impact factor: 3.197

4.  Feline immunodeficiency virus (FIV) infection in domestic pet cats in Australia and New Zealand: Guidelines for diagnosis, prevention and management.

Authors:  M E Westman; S J Coggins; M van Dorsselaer; J M Norris; R A Squires; M Thompson; R Malik
Journal:  Aust Vet J       Date:  2022-05-16       Impact factor: 1.343

5.  Renal alterations in feline immunodeficiency virus (FIV)-infected cats: a natural model of lentivirus-induced renal disease changes.

Authors:  Alessandro Poli; Natasa Tozon; Grazia Guidi; Mauro Pistello
Journal:  Viruses       Date:  2012-08-27       Impact factor: 5.818

Review 6.  Haematological disorders associated with feline retrovirus infections.

Authors:  M L Linenberger; J L Abkowitz
Journal:  Baillieres Clin Haematol       Date:  1995-03

7.  Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection.

Authors:  R Hofmann-Lehmann; E Holznagel; A Aubert; P Ossent; M Reinacher; H Lutz
Journal:  Vet Immunol Immunopathol       Date:  1995-05       Impact factor: 2.046

Review 8.  Feline immunodeficiency. ABCD guidelines on prevention and management.

Authors:  Margaret J Hosie; Diane Addie; Sándor Belák; Corine Boucraut-Baralon; Herman Egberink; Tadeusz Frymus; Tim Gruffydd-Jones; Katrin Hartmann; Albert Lloret; Hans Lutz; Fulvio Marsilio; Maria Grazia Pennisi; Alan D Radford; Etienne Thiry; Uwe Truyen; Marian C Horzinek
Journal:  J Feline Med Surg       Date:  2009-07       Impact factor: 2.015

9.  Seroepidemiological and clinical survey of feline immunodeficiency virus infection in northern Italy.

Authors:  E V Peri; W Ponti; P Dall'ara; M Rocchi; A Zecconi; L Bonizzi
Journal:  Vet Immunol Immunopathol       Date:  1994-04       Impact factor: 2.046

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.